Close Menu
    What's Hot

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Insurance Regulator Takes a Look at Funded Reinsurance

    Longevity and Mortality Risk Transfer August 10, 2023By Michael Abramson and Lara Desay
    Share
    Twitter LinkedIn Email

    On 15 June 2023 the Prudential Regulatory Authority (PRA) published a letter to bulk annuity insurers regarding their use of funded reinsurance. In this note we seek to help pension schemes understand what funded reinsurance is, its relevance to them, and what the PRA has concluded. 

    Funded reinsurance is akin to a bulk annuity insurer doing its own buy-in behind the scenes. The insurer takes a portion of the buy-in/buy-out premium received from the pension scheme and passes it on to a reinsurer, often but not necessarily overseas. The reinsurer is then on the hook for providing monthly benefit payments to the insurer, and the insurer passes these payments on to the pension scheme or (following buy-out) the pensioners directly. 

    Reasons for use of funded reinsurance 

    Insurers typically use funded reinsurance for one or a combination of the following reasons: 

    • Investing quickly at scale. E.g. for a £1bn buy-in an insurer could use funded reinsurance for 50% and only need to source £500m of assets rather than £1bn.
    • Capital efficiency / scale. The insurer can use less capital for writing the business if the risk is shared – either helping the insurer to write a larger buy-in/buy-out, or improve its return on capital. Insurers may even end up with an improved capital position by writing the business, an unusual position for bulk annuities.
    • Pricing. The pricing offered by the reinsurer may be sufficiently attractive that it is more profitable for the insurer to pass on the risks than retain them.

    Risk 

    If an insurer uses reinsurance on a particular buy-in or buy-out, this does not directly expose the pension scheme (or its members) to the reinsurer. If the reinsurance fails in any way, the insurer remains on the hook. But pension schemes should still consider the overall risk profile of a selected insurer, including the exposure that insurer has to reinsurers and how associated risks are managed. The use of reinsurance, be it funded or pure longevity, can vary significantly between insurers. Funded reinsurance has more inherent risk than longevity reinsurance, as the asset risk is passed across to the reinsurer at outset, so if the reinsurer fails, there is a potentially sizeable loss for the insurer. 

    How do insurers manage these risks? 

    Insurers use a suite of contractual protections and collateral arrangements to protect against a reinsurer’s financial strength deteriorating, as well as planned management actions should this occur. The idea in simple terms is that at (or ideally before) the point of a reinsurer failing, the insurer can step in and take control of a portfolio of assets that they can then use to back the liabilities themselves. 

    PRA letter 

    The PRA letter shares their insights from a review of funded reinsurance across the sector. It goes into more detail about the risks inherent in funded reinsurance and how insurers are currently mitigating these. The PRA’s key conclusions thus far are: 

    • There is a positive trend of improvement in insurers’ risk frameworks and models relating to funded reinsurance.
    • However, insurer practices still showed some material shortcomings, in particular some structural risks with regard to collateral portfolios and the assumptions made about the impact of possible reinsurer failure.
    • There are limited risks to policyholder security from the use of funded reinsurance within a diversified asset strategy, but there could be significant risks if funded reinsurance were to be used systemically as a way of meeting increased demand for buy-in and buy-out.

    The PRA set out a number of next steps, the main ones being: 

    • Insurers will need to consider whether the letter requires any remedial actions on their part.
    • The PRA plans further supervisory work around insurer use of funded reinsurance, and will consider whether any further policy is required
    • Insurers need to notify the PRA regarding any material funded reinsurance transactions they enter into.

    In summary 

    Given the expected rapid growth in insurer balance sheets as more and more DB pension schemes seek to pass them their liabilities, we are encouraged that the PRA is scrutinising the use of funded reinsurance – especially given that assets and liabilities are commonly passed to reinsurers who are based overseas and therefore outside of the PRA’s remit. The PRA appears to be accepting of the moderate use of funded reinsurance, but remains concerned about a scenario where its systemic use leads to the majority of UK DB assets and liabilities end up moving outside of the Pensions Regulator or PRA remit. We support this overall direction of travel, as well as a continued PRA focus on ensuring that where insurers do use funded reinsurance, they have appropriate risk mitigations in place. 

    For pension schemes with existing buy-ins or who are considering their use, we believe trustees and sponsors should take comfort from the PRA’s approach. We suggest pension schemes consider the use of funded reinsurance when assessing the financial strength of a given insurer. 

    Michael Abramson is a Partner and Risk Transfer Specialist; Lara Desay is a Partner and Risk Transfer Specialist at Hymans Robertson 


    This communication has been compiled by Hymans Robertson LLP, and is based upon their understanding of legislation and events as at date of publication. It is designed to be a general information summary and may be subject to change. It is not a definitive analysis of the subject covered or specific to the circumstances of any particular employer, pension scheme or individual. The information contained is not intended to constitute advice, and should not be considered a substitute for specific advice in relation to individual circumstances. Where the subject of this document involves legal issues you may wish to take legal advice. Hymans Robertson LLP accepts no liability for errors or omissions or reliance on any statement or opinion. 

    Hymans Robertson LLP (registered in England and Wales – One London Wall, London EC2Y 5EA – OC310282) is authorised and regulated by the Financial Conduct Authority and licensed by the Institute and Faculty of Actuaries for a range of investment business activities. A member of Abelica Global. © Hymans Robertson LLP. 

    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2023 - August Commentary Longevity Risk Pension Risk Transfer Regulation Volume 2 Issue 8 - August 2023
    Share. Twitter LinkedIn Email

    Related Posts

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026By Mark McCord
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026By Greg Winterton

    Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

    July 22, 2026By Greg Winterton

    UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

    July 20, 2026By LMI Newsdesk
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.